Logo

Whatariff.com

Global Tariffs, Categorized

🇺🇸 United States
🌍 Select Country
📦 Ampicillin and its salts

Ampicillin and its salts

HS Code:

📦

Overview

Ampicillin and its salts fall under HS Code 29411020, which covers antibiotics of the penicillin group. Ampicillin is a broad-spectrum antibiotic used to treat a variety of bacterial infections. It is commonly used in both human and veterinary medicine. The global trade of Ampicillin and its salts is driven by demand in the pharmaceutical industry, particularly in countries with large healthcare sectors or significant generic drug manufacturing capabilities. Trade patterns are influenced by production capacity, regulatory standards, and intellectual property laws surrounding antibiotic manufacturing.

Total Trade Volume

USD 250 million

Data from 2022

Source

United Nations Comtrade Database, World Trade Organization (WTO)

Tariff Analysis

Average Rate

5.2%

Highest Rate

10% (applied by certain developing countries to protect domestic industries)

Lowest Rate

0% (under free trade agreements like EU-India FTA for specific partners)

Common Restrictions

  • Import licensing requirements for pharmaceutical products
  • Good Manufacturing Practice (GMP) certification mandatory for exporters
  • Anti-dumping duties in some regions to prevent price undercutting
  • Quotas on imports in countries with domestic production incentives

Market Trends

Rising demand for generic antibiotics

Increased export volumes from India and China due to cost-effective production and expiration of patents

2021-2022

Stringent regulatory requirements in developed markets

Higher compliance costs for exporters, limiting smaller players from entering markets like the EU and US

2020-2022

Shift towards sustainable production

Growing pressure on manufacturers to adopt environmentally friendly production methods, influencing trade costs

2022

Recent Developments

India's New Pharmaceutical Export Incentive

The Indian government introduced a Production Linked Incentive (PLI) scheme to boost domestic manufacturing and export of antibiotics like Ampicillin.

March 2023

Expected to increase India's share in global trade by 5-7% over the next 3 years.

EU Tightens Antibiotic Import Regulations

The European Union implemented stricter guidelines for antibiotic imports, requiring detailed supply chain transparency to combat antimicrobial resistance.

January 2023

May lead to reduced imports from non-compliant countries and higher costs for exporters.

US-China Trade Agreement on Pharmaceuticals

A new trade agreement between the US and China includes provisions to reduce tariffs on certain pharmaceutical products, including Ampicillin.

September 2022

Likely to boost China's export volume to the US market, intensifying competition with other suppliers.